Publication | Open Access
Efficacy and safety of entrectinib in patients with NTRK fusion-positive (NTRK-fp) Tumors: Pooled analysis of STARTRK-2, STARTRK-1 and ALKA-372-001
63
Citations
0
References
2018
Year
Surgical OncologyMedicineCancer ManagementPathologyMolecular OncologyCancer TreatmentOncologyRadiation OncologyCancer Research
No additional data available for this publication yet. Check back later!